Trastuzumab and vinorelbine as first-line therapy for HER2-overexpressing metastatic breast cancer: multicenter phase II and pharmacokinetic study in Japan.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples